Tatiana Slonskaya

Tatiana Slonskaya

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 1997 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
YEYu. A. Ershov
Yu. A. Ershov
TPT. V. Pleteneva
T. V. Pleteneva
TSTatiana Slonskaya
Tatiana Slonskaya

1 January 2020 in Voprosy praktičeskoj pediatrii
Verified
Journal Article
Closed access
VYV.G. Yankova
V.G. Yankova
IUI.L. Udyanskaya
I.L. Udyanskaya
SGS.V. Grigoryeva
S.V. Grigoryeva
TSTatiana Slonskaya
Tatiana Slonskaya
AZA.A. Zhukova
A.A. Zhukova
PKP.A. Karpova
P.A. Karpova
Lactofiltrum is a combination drug, pharmacological action of which is associated with the properties of its active components, namely lignin and lactulose. The effects of Lactofiltrum include normalization of the colon microbiota, decrease in the intensity of endogenous toxic conditions, and possibility of using it in patients of different age (the drug is recommended for adults and children >1 year of age); these properties of Lactofiltrum explain its popularity among doctors of various specialties and patients. Objective. To analyze the binary activity of Lactofiltrum using the methods of qualitative and quantitative assessment of the adsorption and prebiotic actions. Materials and methods. Microphotographs of the morphology and surface texture of Lactofiltrum were obtained using the OlympusBX-51 optical microscope. The following methods were proposed for qualitative and quantitative assessment of the adsorption and prebiotic actions of Lactofiltrum: method of ‘visual qualitative assessment of the enterosorbent adsorption activity’ and reverse complexometric titration. Prebiotic activity was evaluated using microbiological methods. Conclusion. Our experimental study confirmed high adsorption and prebiotic activity of Lactofiltrum. Key words: adsorption and prebiotic activity, Lactofiltrum, microbiocenosis, drug for children older than 1 year of age

1 January 2023 in Voprosy praktičeskoj pediatrii
Verified
Journal Article
Closed access
SGS.V. Gribanova
S.V. Gribanova
VYV.G. Yankova
V.G. Yankova
OGOleg Gobyzov
Oleg Gobyzov
MRMikhail Ryabov
Mikhail Ryabov
AKA.S. Karpova
A.S. Karpova
LSL.A. Simonyan
L.A. Simonyan

1 January 2022 in Voprosy praktičeskoj pediatrii
Verified
Journal Article
Closed access
VYV.G. Yankova
V.G. Yankova
IUI.L. Udyanskaya
I.L. Udyanskaya
TSTatiana Slonskaya
Tatiana Slonskaya
AZA.A. Zhukova
A.A. Zhukova
VGVictoria Grigorieva
Victoria Grigorieva
MIMoscow The Institution «Project Center Iter»
Moscow The Institution «Project Center Iter»
Enterosorbents based on lignin hydrolised are able to adsorb in the intestine different kinds of toxins, drugs, salts of heavy metals etc. Nowadays, such drugs are widely applied during the treatment of the adults and children from the first year of life due to its safety and proven efficacy. Objective. To study the morphology and the adsorption centers on the surface of the enterosorbent "Filtrum-STI" based on lignin hydrolised. To develop a methodology for determination the adsorption activity of the drug "Filtrum-STI" and to measure qualitatively and quantitatively its adsorption activity to low molecular weight toxins and heavy metals. Materials and methods. The morphology of the sample’s surface was investigated on an Olympus BX-51 optical microscope. IR spectra were obtained using a Thermo Nicolet Nexus 470 FT-IR infrared Fourier spectrometer. Visual identification of the adsorption activity of the enterosorbent was carried out using methylene blue and methyl orange, recommended by the RF SPh as models of low molecular weight toxins. The methodology of determination the adsorption activity to heavy metal cations was developed and the measurements of this activity were carried out using reverse complexometric titration towards Pb2+ cation. Results. Micrographs of the sample "Filtrum-STI" demonstrate the heterogeneity of its surface morphology, the tablet consists of small particles. IR spectroscopy confirmed the presence of active adsorption centers on the surface of lignin hydrolysed. Adsorption of low molecular weight toxins from aqueous solutions was obviously revealed after 15 minutes for all toxins. It is estimated that the adsorption activity of the drug is preserved at physiological pH. The mass content of adsorbed Pb2+ cations was determined by the method of reverse complexometric titration, was demonstrated that w = 19.44 ± 0.92% of cations were adsorbed. Conclusion. A methodology of the determination the adsorption activity of the enterosorbent "Filtrum-STI" was developed and successfully tested, it allowed to confirm the high adsorption properties of the studied drug to a wide range of markers in various media. Key words: enterosorbent, lignin hydrolysed, "Filtrum-STI", adsorption activity, toxins, adsorption centers

1 January 2025 in Voprosy praktičeskoj pediatrii
Verified
Journal Article
Closed access
VYV.G. Yankova
V.G. Yankova
OGOleg Gobyzov
Oleg Gobyzov
MRMikhail Ryabov
Mikhail Ryabov
VGVictoria Grigorieva
Victoria Grigorieva
IUI.L. Udyanskaya
I.L. Udyanskaya
SGS.V. Gribanova
S.V. Gribanova
The effectiveness of delivery of pharmaceutical sprays containing the same active substance in the same concentration to the focal point of inflammation in the treatment of throat diseases depends on the quality of spraying of the drug. Objective. Comparative analysis of the spray parameters of 8 benzidamine drugs produced in the form of a metered-dose spray to select a drug with optimal spray quality characteristics. Materials and methods. The study included 8 drugs in the form of metered-dose sprays for topical use containing benzydamine and approved for use in children aged 3 years and older: Tantum® Verde (marketing certificate holder Angelini Pharma SpA, Italy), Oralsept® (marketing certificate holder Gedeon Richter Plc., Hungary), Lorangin® (marketing certificate holder Penta Group Research and Production Association LLC, Russia), VERTUM-LOR (VERTEX JSC, Russia), Faringosprey (marketing certificate holder Sun Pharmaceutical Industries Ltd., India), FARINORM® Benzydamine (marketing certificate holder YuzhPharm LLC, Russia), INLARTEX (marketing certificate holder Tula Pharmaceutical Factory LLC, Russia), Anestojet (marketing certificate holder IRIS LLC, Russia). For all samples, the dose mass reproducibility (DMR), spray width and pattern, spray dynamic characteristics, and brightness profile were studied. Results. The AMD test showed that the mean dose masses differ insignificantly, and reproducibility is characterized by a relative error of only 1–2% for all drugs, indicating good dosing stability. The test for spray pattern and distribution, conducted on a simulation model based on the area of a single spray deposition, showed that the widest and most uniform spray, which promotes the most complete deposition of the drugs in the oral cavity, is achieved with Tantum® Verde and Oralsept®. A comparative analysis of the sprays by dynamic characteristics confirmed the conclusion of the previous test that these drugs have the most favorable spray mechanism for delivering the drug to the site of inflammation and correspond to classic sprays. Conclusion. The improved dynamic performance of the drug's spray mechanism facilitates more effective drug delivery to the site of action – the site of inflammation. Tantum® Verde and Oralsept® sprays exhibit the most favorable dynamic performance. Their performance is virtually identical across all tests. Key words: benzydamine, dose mass reproducibility, cone angle, cone shape, acute respiratory infections, metered-dose spray

22 January 2024 in Drug development & registration
Verified
Journal Article
Open access
PDF file
SGS. V. Gribanova
S. V. Gribanova
IUI. L. Udyanskaya
I. L. Udyanskaya
VYV. G. Yankova
V. G. Yankova
TSTatiana Slonskaya
Tatiana Slonskaya
NEN. B. Epshtein
N. B. Epshtein
VKV. N. Kuzina
V. N. Kuzina
Introduction. In modern medicine, the requirements for the quality of used materials are getting stricter. There is serious concern about bacterial and fungal contamination related to the use of silicone polymeric products, especially those that are in direct contact with human tissues and body fluids. In this regard, the issue of impregnating silicone medical products with various biologically active substances (BAS), particularly with antimicrobial properties, appears relevant.Aim. The research studies the relevance of adding BAS into silicone medical devices to improve their quality and prevent negative consequences of their use. The authors of the article aimed at proving prolonged release of the chosen BAS from silicone products during their contact with skin and the bacteriostatic effect emerging as a result of the BAS release. That required verifying the existence of BAS in the washouts from silicone disks, which, in turn, proves the fact that BAS initially distributed evenly in the volume of a silicone disk are capable of diffusing to the surface and then releasing from it under mechanical action, as well as when treating it with alcohol or alcohol-containing solutions.Materials and methods. Symdiol and bisabolol were selected as the BAS for this study due to their proved antibacterial, anti-inflammatory and moisturizing properties. Bisabolol and symdiol were used in the form of Dragosantol 100 and SymDiol 68T preparations correspondingly. Silicone disks (SDs), impregnated with BAS (0,2 % of the volume) were used as a simulation model of silicone liners. The BAS release from silicone liner models was assessed using highly sensitive chromatographic methods of thin-layer and gas-liquid chromatography.Results and discussion. The method of impregnating SDs with BAS was worked out, the optimal concentration of these substances to add them into the silicone base was selected. The release of the impregnated additives, as well as prolonged stable releasing effect, were confirmed. The data obtained during the experiment allows saying with confidence that the impregnated preparation (symdiol and bisabolol) releases from a SD even upon short and low-intensity mechanical contact with skin, which produces stable bacteriostatic effect on a wide range of microorganisms. The process of BAS release from SDs is also facilitated when treating the product periodically with alcohol-containing solutions, which is necessary according to the operating rules. The obtained results of the chromatographic research quite correlate with the data of the previous microbiological experiments regarding the studied topic. Release of the studied BAS from polymer products during their contact with the skin within the period of not less than 3 months justifies feasibility of adding these BAS into the silicone base.Conclusions. The study confirmed the release of biologically active substances from silicone medical products. Adding BAS into silicone liners undoubtedly improves the quality of these medical products, which can be applied in prosthetics and orthoses.